NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Shanghai RAAS Blood Products Co. Ltd (SHE: 002252)
002252 Technical Analysis
4
As on 16th May 2025 002252 SHARE Price closed @ 6.76 and we RECOMMEND Sell for LONG-TERM with Stoploss of 7.34 & Strong Sell for SHORT-TERM with Stoploss of 7.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002252SHARE Price
Open | 6.76 | Change | Price | % |
High | 6.78 | 1 Day | 0.00 | 0.00 |
Low | 6.74 | 1 Week | -0.06 | -0.88 |
Close | 6.76 | 1 Month | -0.10 | -1.46 |
Volume | 16330100 | 1 Year | 0.02 | 0.30 |
52 Week High 8.47 | 52 Week Low 6.20 |
SHE China Most Active Stocks
000981 | 2.15 | 5.39% |
000420 | 4.58 | 1.55% |
002640 | 5.31 | 2.31% |
000559 | 9.41 | 8.29% |
002630 | 2.39 | 4.82% |
002489 | 4.17 | 2.46% |
002165 | 12.44 | 9.99% |
000627 | 2.74 | -9.87% |
000639 | 3.23 | 1.89% |
002094 | 8.64 | 1.89% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
002252 Daily Charts |
002252 Intraday Charts |
Whats New @ Bazaartrend |
002252 Free Analysis |
|
002252 Important Levels Intraday
RESISTANCE | 6.84 |
RESISTANCE | 6.81 |
RESISTANCE | 6.80 |
RESISTANCE | 6.78 |
SUPPORT | 6.74 |
SUPPORT | 6.72 |
SUPPORT | 6.71 |
SUPPORT | 6.68 |
002252 Forecast May 2025
4th UP Forecast | 9.52 |
3rd UP Forecast | 8.63 |
2nd UP Forecast | 8.09 |
1st UP Forecast | 7.54 |
1st DOWN Forecast | 5.98 |
2nd DOWN Forecast | 5.43 |
3rd DOWN Forecast | 4.89 |
4th DOWN Forecast | 4 |
002252 Weekly Forecast
4th UP Forecast | 7.47 |
3rd UP Forecast | 7.24 |
2nd UP Forecast | 7.10 |
1st UP Forecast | 6.96 |
1st DOWN Forecast | 6.56 |
2nd DOWN Forecast | 6.42 |
3rd DOWN Forecast | 6.28 |
4th DOWN Forecast | 6.05 |
002252 Forecast2025
4th UP Forecast | 12.06 |
3rd UP Forecast | 10.36 |
2nd UP Forecast | 9.31 |
1st UP Forecast | 8.26 |
1st DOWN Forecast | 5.26 |
2nd DOWN Forecast | 4.21 |
3rd DOWN Forecast | 3.16 |
4th DOWN Forecast | 1.46 |
Shanghai RAAS Blood Products Co. Ltd ( SHE China Symbol : 002252 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002252 Other Details
Segment | EQ | |
Market Capital | 44758843392.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
002252 Address
![]() |
002252 Latest News
002252 Business Profile
Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. It also provides testing services for blood products, vaccines, diagnostic reagents, and testing equipment. The company also exports its products to Southeast Asia and Latin America. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China. Address: No. 2009, Wangyuan Road, Shanghai, China, 201401
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service